Mar 19, 2018 11:01 am UTC| Business
CAMBRIDGE, Mass., March 19, 2018 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced dosing of the first patient in a...
True Leaf Announces Cannabis Cultivation Team
Mar 19, 2018 11:01 am UTC| Business
VERNON, British Columbia, March 19, 2018 -- True Leaf Medicine International Ltd. (“True Leaf”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and their pets, has recruited two...
TidalScale Extends its Lead in Software-Defined Servers
Mar 19, 2018 11:01 am UTC| Business
CAMPBELL, Calif., March 19, 2018 -- TidalScale, the leader in Software-Defined Servers, announced today the next generation of its award-winning Software-Defined Server technology—what analysts have defined...
Mar 19, 2018 11:01 am UTC| Business
HOUSTON, March 19, 2018 -- News Release – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) released the following statement regarding the Federal Energy Regulatory Commission’s (FERC) recent pronouncements on...
TidalScale Software-Defined Servers Now Support SUSE Linux Enterprise Server
Mar 19, 2018 11:01 am UTC| Business
CAMPBELL, Calif., March 19, 2018 -- TidalScale, the leader in Software-Defined Servers, announced today that working in partnership with SUSE, the world’s first provider of Enterprise Linux, TidalScale has achieved SUSE...
TC PipeLines, LP Provides Initial Response to FERC Orders
Mar 19, 2018 11:01 am UTC| Business
HOUSTON, March 19, 2018 -- News Release – TC PipeLines, LP (NYSE:TCP) (the Partnership) today provided its preliminary assessment of the potential impacts of the Federal Energy Regulatory Commission's (FERC) recent...
Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial
Mar 19, 2018 11:01 am UTC| Business
CALGARY, Alberta, March 19, 2018 -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has successfully surpassed the planned enrollment target of over 2,400 patients in the ongoing...